生物制药商Granata Bio收购Oviva Therapeutics，扩大女性健康产品组合-动脉网

Granata Bio Expands Women's Health Portfolio with Acquisition of USased Oviva Therapeutics

CISION 等信源发布 2025-04-29 20:57



可切换为仅中文







BOSTON

波士顿

，

April 29, 2025

2025年4月29日

/PRNewswire/ -- Granata Bio ('Granata') today announced the acquisition of Oviva Therapeutics, Inc. ('Oviva'), a pioneering women's health biotech company focused on advancing treatments that address female physiology, with an emphasis on ovarian aging.

/PRNewswire/ -- Granata Bio（“Granata”）今天宣布收购Oviva Therapeutics, Inc.（“Oviva”），这是一家专注于推进针对女性生理疗法的先锋女性健康生物技术公司，重点关注卵巢衰老。

Oviva's lead candidate, OVI-586, is a first-in-class therapeutic designed to enhance women's health span— the period of life spent in optimal health— by extending ovarian function. Since the ovaries are the first organ to decline with age, preserving the ovarian reserve presents a novel approach to addressing key women's health challenges.

Oviva的主导候选药物OVI-586是一种首创新药，旨在通过延长卵巢功能来提升女性的健康寿命——即在最佳健康状态下生活的时段。由于卵巢是人体中最早随年龄衰退的器官，保护卵巢储备为解决关键的女性健康问题提供了一种新颖的途径。

OVI-586 holds potential applications across menopause, contraception, and in vitro fertilization (IVF), offering new possibilities for patients seeking advanced reproductive and endocrine health solutions..

OVI-586在更年期、避孕和体外受精（IVF）方面具有潜在的应用价值，为寻求先进生殖与内分泌健康解决方案的患者提供了新的可能性。

'This is a big day for women's health. Cambrian partnered with Drs.

“这对女性健康来说是个重要的日子。Cambrian与博士们合作。

Daisy Robinton

黛西·罗宾顿

，

David Pepin

大卫·佩潘

, and

，以及

Pat Donahue

帕特·多纳休

to found Oviva and develop the first truly novel mechanism in women's health in the last 50 years. We're thrilled about this acquisition and looking forward to seeing Oviva's OVI-586 progress to the next stage of development under Granata's leadership. This transaction reflects the importance of Cambrian's objective: identify amazing scientific discoveries and turn those discoveries into great businesses,' said .

创立Oviva并开发过去50年来女性健康领域首个真正新颖的机制。我们对这次收购感到非常兴奋，并期待在Granata的领导下，Oviva的OVI-586能够进入下一个发展阶段。这笔交易反映了Cambrian目标的重要性：发现卓越的科学成果并将这些成果转化为优秀的企业。”

James Peyer

詹姆斯·佩耶

, Founder and CEO of Cambrian BioPharma, Inc.

Cambrian BioPharma, Inc. 创始人兼首席执行官

'At Granata Bio, our mission is to identify and develop innovative solutions for fertility patients. The acquisition of Oviva Therapeutics marks a significant milestone in our efforts to bring forward new therapies for those with limited treatment options. In IVF stimulation, OVI-586 offers a biologically grounded approach to improving ovarian response— even in patients with diminished ovarian reserve.

“在Granata Bio，我们的使命是为生育患者识别和开发创新解决方案。收购Oviva Therapeutics标志着我们在为那些治疗选择有限的患者推进新疗法方面迈出了重要的一步。在体外受精刺激中，OVI-586提供了一种基于生物学原理的方法来改善卵巢反应——即使是在卵巢储备减少的患者中也是如此。

We're excited to continue advancing OVI-586 and explore its potential in assisted reproductive technology (ART) and beyond,' said Evan Sussman, Co-Founder and CEO of Granata Bio..

“我们很高兴能够继续推进OVI-586，并探索其在辅助生殖技术（ART）及更多领域的潜力，”Granata Bio的联合创始人兼首席执行官Evan Sussman表示。

About Oviva Therapeutics

关于奥维瓦治疗公司

Oviva Therapeutics, Inc. is leading a movement to improve women's experience of aging through biomedical research, development and advocacy. Oviva addresses the vast unmet need in women's health by expanding funding, research, and clinical development, and is currently developing first-in-class therapeutics to improve ovarian function and consequently extend female healthspan.

Oviva Therapeutics, Inc. 正在通过生物医学研究、开发和倡导来引领改善女性衰老体验的运动。Oviva 通过扩大资金、研究和临床开发来应对女性健康领域巨大的未满足需求，目前正在开发首创疗法以改善卵巢功能，从而延长女性的健康寿命。

。

www.ovivatx.com

About Granata Bio

关于Granata Bio

Granata Bio is a U.S.-based biopharmaceutical company dedicated to advancing innovation in women's health and infertility. Founded in 2018, the company's pipeline includes a range of fertility therapies, with collaborations spanning multiple drug classes to address unmet needs in reproductive medicine.

Granata Bio是一家总部位于美国的生物制药公司，致力于推动女性健康和不孕症领域的创新。公司成立于2018年，其研发管线包括一系列生育治疗药物，并通过跨多类药物的合作来满足生殖医学中未被满足的需求。

。

www.granata.bio

For all inquiries contact

如有任何疑问，请联系

info@granata.bio

。

SOURCE Granata Bio

源格拉纳塔生物

WANT YOUR COMPANY'S NEWS

希望贵公司的新闻

FEATURED ON PRNEWSWIRE.COM?